Muscle morphogenic protein and use thereof
AssigneeMassachusetts Institute of Technology
InventorsPaul A. Lucas, Henry E. Young, Cato T. Laurenchin
Life of this patent
Estimating the term…
Loading patent…
AssigneeMassachusetts Institute of Technology
InventorsPaul A. Lucas, Henry E. Young, Cato T. Laurenchin
Estimating the term…
A myogenic protein isolate from mammalian bone is provided that stimulates lineage commitment and differentiation of stem cells in vitro and in vivo. The protein isolate is characterized by its ability to cause muscle stem cell differentiation without excessive proliferation of connective tissue proximal to the delivery site. Treated muscle stem cells differentiate into myotubes and multinucleated structures with minimal formation of scar tissue, resulting in functional muscle tissue restoration in vivo, and therefore useful in the treatment of a number of disorders and injuries. The protein isolate is preferably administered by implanting a bioerodible polymer matrix, preferably a surface erodible polymer such as a polyanhydride or a polyorthoester, interspersed with the protein isolate near the site of muscle injury or degeneration, but can be administered directly to cells cultured in vitro.
A protein isolate comprising one or more water soluble proteins isolated from mammalian bone, wherein the protein isolate selectively stimulates stem cell myogenic lineage commitment and differentiation into myotubes and multinucleated structures in vitro and in vivo, contains proteins having molecular weights between 50,000 and 200,000 daltons, does not bind to DEAE in urea at pH 6.0, and binds to a cation exchange column at pH 6.0.
A method of inducing myogenesis n undifferentiated stem cells in culture or in a patient in need of treatment thereof comprising administering a therapeutically effective amount of between approximately 1 ng and 10 mg per kilogram of stem cells or body weight of a water soluble protein isolate extracted from mammalian bone to the stem cells to induce myogenic lineage commitment and differentiation into myotubes and multinucleated structures, wherein the protein isolate contains proteins having molecular weights between 50,000 and 200,000 daltons, does not blind to DEAE in urea at pH 6.0, and binds to a cation exchange column at pH 6.0.
Dependencies are inferred from the claim text.